Massachusetts General Hospital_Site number 002

Boston, Massachusetts 02114

0 studies enrolling now · 2 studies all time

What they study most

Chronic Graft-versus-host-disease, Diffuse Cutaneous Systemic Sclerosis, System; Sclerosis

Studies at this site

• Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy — Stopped early
• KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis — Stopped early